KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Non-Current Debt: 2012-2020

Historic Non-Current Debt for Nektar Therapeutics (NKTR) over the last 7 years, with Mar 2020 value amounting to $254.8 million.

  • Nektar Therapeutics' Non-Current Debt rose 3.00% to $254.8 million in Q1 2020 from the same period last year, while for Mar 2020 it was $254.8 million, marking a year-over-year increase of 3.00%. This contributed to the annual value of $250.0 million for FY2019, which is 1.24% up from last year.
  • As of Q1 2020, Nektar Therapeutics' Non-Current Debt stood at $254.8 million, which was up 1.92% from $250.0 million recorded in Q4 2019.
  • In the past 5 years, Nektar Therapeutics' Non-Current Debt ranged from a high of $254.8 million in Q1 2020 and a low of $242.1 million during Q1 2016.
  • In the last 3 years, Nektar Therapeutics' Non-Current Debt had a median value of $247.4 million in 2019 and averaged $248.2 million.
  • Data for Nektar Therapeutics' Non-Current Debt shows a peak YoY surged of 94.05% (in 2016) over the last 5 years.
  • Over the past 5 years, Nektar Therapeutics' Non-Current Debt (Quarterly) stood at $243.5 million in 2016, then rose by 0.72% to $245.2 million in 2017, then grew by 0.71% to $246.9 million in 2018, then increased by 1.24% to $250.0 million in 2019, then increased by 3.00% to $254.8 million in 2020.
  • Its Non-Current Debt was $254.8 million in Q1 2020, compared to $250.0 million in Q4 2019 and $248.3 million in Q3 2019.